NCT02603328 2025-08-22
AT CASH EPOC
University of Chicago
Phase 1/2 Completed
Clinical Trials
13 trialsNCT05085561 2025-08-06
SYCAMORE
Recursion Pharmaceuticals Inc.
Phase 2 Completed
NCT06214767 2025-07-30
Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations
Beijing Tiantan Hospital
Recruiting
NCT07026604 2025-06-18
CCM-DS01
Beijing Tiantan Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT01764529 2025-05-29
Modifiers of Disease Severity in Cerebral Cavernous Malformations
University of California, San Francisco
Active not recruiting
NCT03652181 2024-06-27
CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
University of Chicago
Completed
NCT03474614 2024-04-19
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
St. Joseph's Hospital and Medical Center, Phoenix
Phase 2 Terminated
NCT01764451 2024-03-12
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
University of New Mexico
Phase EARLY_PHASE1 Terminated
NCT05148663 2023-09-01
CCM Blood Biomarker Validation Study
Texas Tech University Health Sciences Center, El Paso
Terminated
NCT02946866 2022-05-12
CHOCOOATE
Seoul National University Hospital
Unknown
NCT03589014 2022-02-25
Treat_CCM
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT04076449 2019-09-04
CRESS
Beijing Tiantan Hospital
Recruiting
NCT03467295 2018-03-19
TOUCH
First Affiliated Hospital of Fujian Medical University
Unknown